- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
TwinStrand Biosciences, Inc. v. Guardant Health, Inc.
Appellant | TWINSTRAND BIOSCIENCES, INC. |
Appellee | GUARDANT HEALTH, INC. |
Twinstrand Biosciences, Inc. | |
... |

- Search within this case
Analyze Party
Analyze Firm
Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al
Division | Wilmington |
Flags | PATENT |
Cause | 35:271 Patent Infringement |
Case Type | 830 Patent |
Tags | 830 Patent, 830 Patent |
Plaintiff | Breckenridge Pharmaceutical, Inc. |
Defendant | Hetero USA Inc. |
Defendant | Hetero Labs Limited Unit - III |
... |

- Search within this case
Analyze Judge
Analyze Party
Analyze Firm
Takeda Vaccines, Inc. v. Valneva Austria GmbH
Case Type | Inter Partes Review |
Patent | 11219681 |
Patent Owner | Valneva Austria GmbH |
Petitioner | Takeda Vaccines, Inc. |
Assignee | WILMINGTON TRUST, NATIONAL ASSOCIATION |

- Search within this case
Analyze Judge
Analyze Party
Analyze Firm
Scale Biosciences, Inc. v. Parse Biosciences, Inc. et al
Division | Wilmington |
Flags | Multi-Media Docs, PATENT |
Cause | 35:1 Patent Infringement |
Case Type | 830 Patent |
Tags | 830 Patent, 830 Patent |
Deadline | Release of Transcript Restriction set for 4/9/2025. |
Deadline | 30th May Christopher J. Burke UNITED STATES MAGISTRATE JUDGE 7 Event Close of fact discovery Final supplement identifying all accused products and all invalidity references Final infringement contentions Final invalidity contentions Case Narrowing Step One: Initial narrowing of asserted claims to no more than 32 claims for Plaintiffs and 24 claims for Counterclaim Plaintiffs Opening expert reports Rebuttal expert reports Reply expert reports Close of discovery, including expert discovery Case Narrowing Step Two: Narrowing of asserted claims to no more than 24 claims for Plaintiffs and 18 claims for Counterclaim Plaintiffs Case dispositive & Daubert motions Hearing on case dispositive & Daubert motions Case Narrowing Step Three: Narrowing of asserted claims to no more than 16 claims for Plaintiffs and 12 claims for Counterclaim Plaintiffs Joint Proposed Pretrial Order (incorporating motions in limine) Proposed preliminary and final jury instructions, voir dire, and special verdict forms Pretrial conference Tri, 13. (Case Narrowing Step Three) The parties shall narrow the asserted claims to no more than 16 claims for Plaintiffs and 12 claims for Counterclaim Plaintiffs by April 11, 2025 with those claims selected from those identified by the parties at Case Narrowing Step Two |
Plaintiff | Scale Biosciences, Inc. |
Plaintiff | Roche Sequencing Solutions, Inc. |
Defendant | Parse Biosciences, Inc. |
... |

- Search within this case
Analyze Judge
Analyze Party
Analyze Firm
Pierre Fabre Medicament SAS, et al. v. Annora Pharma Private Limited
Division | Wilmington |
Flags | CLOSED, PATENT |
Cause | 35:271 Patent Infringement |
Case Type | 835 Patent - Abbreviated New Drug Application (ANDA) |
Tags | 835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda |
Deadline | Date of Expiration of Patent: 10/16/2028.Thirty Month Stay Deadline: 3/19/2025. |
Plaintiff | Pierre Fabre Medicament SAS |
Plaintiff | Centre Hospitalier Universitaire de Bordeaux |
Plaintiff | Pierre Fabre Pharmaceuticals, Inc. |
... |

- Search within this case
Analyze Judge
Analyze Party
Analyze Firm
TwinStrand Biosciences, Inc. v. Guardant Health, Inc.
|

Guardant Health, Inc. v. University of Washington
|

Guardant Health, Inc. v. University of Washington
|
